Cytek Biosciences (CTKB) Invested Capital (2022 - 2026)
Cytek Biosciences (CTKB) posted Invested Capital of $386000.0 for Q1 2026, down 26.48% on a QoQ basis from $525000.0 in Q4 2025, and down 57.95% year-over-year from $918000.0 in Q1 2025.
Cytek Biosciences (CTKB) Invested Capital (2022 - 2026) Analysis & Trends
Cytek Biosciences' Invested Capital history runs 5 years deep, the most recent figure standing at $386000.0 for Q1 2026.
- Quarterly Invested Capital fell 57.95% year-over-year to $386000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 48.01% YoY) and the FY2025 annual result came in at $525000.0, down 50.0% from the prior year.
- Invested Capital was $386000.0 for Q1 2026 at Cytek Biosciences, down from $525000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $2.3 million in Q4 2022 and bottomed at $386000.0 in Q1 2026.
- A 5-year average of $1.3 million and a median of $1.3 million in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2023 — Invested Capital fell 27.43% — and 2026, when it plunged 57.95%.
- Cytek Biosciences' Invested Capital stood at $2.3 million in 2022, then decreased by 27.43% to $1.6 million in 2023, then slumped by 36.29% to $1.0 million in 2024, then plunged by 50.0% to $525000.0 in 2025, then decreased by 26.48% to $386000.0 in 2026.
- Business Quant data shows CTKB's Invested Capital at $386000.0 in Q1 2026, $525000.0 in Q4 2025, and $655000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.41 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 499.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 1.41 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 7.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 15.00 Mn |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn | 386,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 386,000.00 |
| Dec 31, 2025 | 525,000.00 |
| Sep 30, 2025 | 655,000.00 |
| Jun 30, 2025 | 791,000.00 |
| Mar 31, 2025 | 918,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 1.88 Mn |
| Mar 31, 2023 | 2.13 Mn |
| Dec 31, 2022 | 2.27 Mn |